|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit for the year | |||||
| Adjustments for: | |||||
| Depreciation | |||||
| Amortization | |||||
| Impairment of intangible assets | |||||
| Impairment provision for non-financial assets | |||||
| Intangible assets written off | |||||
| Gain on discontinuation of equity accounted investments | |||||
| Net gain on de-recognition of property, plant and equipment | |||||
| Gain on lease modification | |||||
| Net finance (income) costs | |||||
| Share of (profit) loss of equity-accounted investees | |||||
| Share based payment | |||||
| Income tax (benefit) expense | |||||
| Operating cash flows before changes in following assets and liabilities | |||||
| Changes in: | |||||
| Inventories | |||||
| Trade and other receivables and contract assets | |||||
| Other assets | |||||
| Trade and other payables and contract liabilities and related payables | |||||
| Employee benefits | |||||
| Other liabilities | |||||
| Cash generated from operating activities | |||||
| Income tax paid, net | |||||
| Net cash generated from operating activities | |||||
| Cash flows from investing activities | |||||
| Interest received | |||||
| Acquisition of property, plant and equipment (refer note (a) below) | |||||
| Acquisition of intangible assets | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Redemption of term deposits | |||||
| Investment in term deposits | |||||
| Acquisition of subsidiary/business,net of cash acquired (refer note 7(b)-7(d) and note (b) below) | |||||
| Loan given to equity-accounted investee received back (refer note 37) | |||||
| Payment of contingent consideration (refer note 7 (c)) | |||||
| Investment in equity securities (refer note 9) | |||||
| Acquisition of other securities measured at fair value through profit or loss | |||||
| Income tax paid on term deposits | |||||
| Net cash generated from (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of convertible notes due 2030 (refer note 28) | |||||
| Payment towards repurchase of own shares (refer note 26) | |||||
| Direct cost incurred in relation to issuance of ordinary shares and convertible notes due 2030 | |||||
| Repurchase of convertible notes (refer note 28) | |||||
| Repurchase of treasury shares (refer note 26) | |||||
| Acquisition of non-controlling interest (refer note 7(a)) | |||||
| Settlement of share based arrangement (refer note 33 (d) (i)) | |||||
| Proceeds from issuance of shares on exercise of share based awards | |||||
| Proceeds from bank loans (refer note 28) | |||||
| Repayment of bank loans (refer note 28) | |||||
| Payment of principal portion of lease liabilities (refer note 28) | |||||
| Interest paid, including finance and other charges (refer note 16 and 28) | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Effect of exchange rate fluctuations on cash held | |||||
| Cash and cash equivalents at end of the year (refer note 22) | |||||
| Supplementary information: non-cash transactions | |||||
| (a) Property, plant and equipment acquired through secured bank loans (refer note 28) | |||||
| (b) Transfer of right to receive collection from trade receivables used to settle purchase consideration (refer note 7 (c)) | |||||
Loading...
